Inst. Portugues de Oncologia de Porto Francisco Gentil EPE ( Site 1400)

Porto 4200-072

0 studies enrolling now · 1 studies all time

What they study most

Squamous Cell Carcinoma of Head and Neck

Studies at this site

• Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009) — Completed